List of cell lines used in the study
Name . | Characteristics . | Original publications . |
|---|---|---|
| DG75 | EBV-negative BL | Ben-Bassat et al25 |
| DG75-Akata cl.2-2; 6 | DG75 infected with Akata-NeoR | Maeda et al26 |
| Daudi | EBV-positive BL with EBNA-2-deficient genome | Klein et al27 |
| P3HR1 | EBV-positive BL with EBNA-2-deficient genome | Hinuma et al28 |
| Sal | EBV-positive BL with EBNA-2-deficient and wild-type genomes | Kelly et al29 |
| Mutu I cl.148 | EBV-positive, type I BL | Gregory et al30 |
| Akata | EBV-positive, type I BL | Takada et al31 |
| Mutu III cl.99 | EBV-positive, type III BL | Gregory et al30 |
| Raji | EBV-positive, type III BL | Epstein et al32 |
| Jijoye P79 | EBV-positive, type III BL | Andersson et al33 |
| ER/EB2-5 | Conditional LCL with estrogen-receptor-EBNA-2 fusion gene | Kempkes et al34 |
| P493-6 | Conditional c-myc-transfected ER/EB2-5 | Polack et al35 |
| A1 | c-myc-transfected ER/EB2-5 | Polack et al35 |
| B95-8 LCL | LCL established in our laboratory with the B95-8 strain | Unpublished |
| Akata LCL | LCL established in our laboratory with Akata-NeoR strain | Unpublished |
| SNK-6 | EBV-positive, LMP-1-positive NK lymphoma | Nagata et al36 |
| KAI-3 | EBV-positive, LMP-1-positive NK lymphoma | Tsuge et al37 |
| Jurkat | EBV-negative T-ALL | Schneider et al38 |
Name . | Characteristics . | Original publications . |
|---|---|---|
| DG75 | EBV-negative BL | Ben-Bassat et al25 |
| DG75-Akata cl.2-2; 6 | DG75 infected with Akata-NeoR | Maeda et al26 |
| Daudi | EBV-positive BL with EBNA-2-deficient genome | Klein et al27 |
| P3HR1 | EBV-positive BL with EBNA-2-deficient genome | Hinuma et al28 |
| Sal | EBV-positive BL with EBNA-2-deficient and wild-type genomes | Kelly et al29 |
| Mutu I cl.148 | EBV-positive, type I BL | Gregory et al30 |
| Akata | EBV-positive, type I BL | Takada et al31 |
| Mutu III cl.99 | EBV-positive, type III BL | Gregory et al30 |
| Raji | EBV-positive, type III BL | Epstein et al32 |
| Jijoye P79 | EBV-positive, type III BL | Andersson et al33 |
| ER/EB2-5 | Conditional LCL with estrogen-receptor-EBNA-2 fusion gene | Kempkes et al34 |
| P493-6 | Conditional c-myc-transfected ER/EB2-5 | Polack et al35 |
| A1 | c-myc-transfected ER/EB2-5 | Polack et al35 |
| B95-8 LCL | LCL established in our laboratory with the B95-8 strain | Unpublished |
| Akata LCL | LCL established in our laboratory with Akata-NeoR strain | Unpublished |
| SNK-6 | EBV-positive, LMP-1-positive NK lymphoma | Nagata et al36 |
| KAI-3 | EBV-positive, LMP-1-positive NK lymphoma | Tsuge et al37 |
| Jurkat | EBV-negative T-ALL | Schneider et al38 |
T-ALL indicates T-cell acute lymphoblastic leukemia.